Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fitzgerald

Showing results (171-180 of 2,130) with videos related to

Pageof 213
Sort By:
Clinical Pharmacology and Therapeutics|September 15, 2017
Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin PreparationsDermot Cox, Desmond J Fitzgerald
American Heart Journal|May 20, 1998
Long-term administration of glycoprotein IIb/IIIa antagonistsM Quinn, D J Fitzgerald
Journal of Anatomy|December 1, 1986
Motor innervation of rodent diaphragmT Comerford, M J Fitzgerald
Irish Journal of Medical Science|August 13, 2016
A case of Hirschsprung's disease with adrenogenital syndrome and skeletal anomaliesA Hayes, R J Fitzgerald
Die Nahrung|July 18, 2003
Characterisation and quantification of the reaction(s) catalysed by transglutaminase using the o-phthaldialdehyde reagentJohn Flanagan, Richard J FitzGerald
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 1, 1986
Antenatal ultrasound diagnosis of cystic adenomatoid malformation of the lungE J Fitzgerald, A Toi
Seminars in Vascular Medicine|June 17, 2004
Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?Andrew Maree, Desmond J Fitzgerald
Hospital Material[Dollar Sign] Management|July 7, 1992
I.v. free-flow risk creates alarm, possible price changesJ Fitzgerald, J M Diekman
Circulation|November 1, 1992
Subcutaneous heparin during coronary thrombolysis. Too little, too lateN Delanty, D J Fitzgerald
Revista Espanola De Cardiologia|September 27, 2008
Evaluation of vessel response to percutaneous coronary interventionPeter J Fitzgerald, Hiromasa Otake
Pageof 213

Showing results (171-180 of 2,130) with videos related to

Sort By:
Pageof 213
Clinical Pharmacology and Therapeutics|September 15, 2017
Lack of Bioequivalence Among Low-dose, Enteric-coated Aspirin PreparationsDermot Cox, Desmond J Fitzgerald
American Heart Journal|May 20, 1998
Long-term administration of glycoprotein IIb/IIIa antagonistsM Quinn, D J Fitzgerald
Journal of Anatomy|December 1, 1986
Motor innervation of rodent diaphragmT Comerford, M J Fitzgerald
Irish Journal of Medical Science|August 13, 2016
A case of Hirschsprung's disease with adrenogenital syndrome and skeletal anomaliesA Hayes, R J Fitzgerald
Die Nahrung|July 18, 2003
Characterisation and quantification of the reaction(s) catalysed by transglutaminase using the o-phthaldialdehyde reagentJohn Flanagan, Richard J FitzGerald
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|March 1, 1986
Antenatal ultrasound diagnosis of cystic adenomatoid malformation of the lungE J Fitzgerald, A Toi
Seminars in Vascular Medicine|June 17, 2004
Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: where are we now?Andrew Maree, Desmond J Fitzgerald
Hospital Material[Dollar Sign] Management|July 7, 1992
I.v. free-flow risk creates alarm, possible price changesJ Fitzgerald, J M Diekman
Circulation|November 1, 1992
Subcutaneous heparin during coronary thrombolysis. Too little, too lateN Delanty, D J Fitzgerald
Revista Espanola De Cardiologia|September 27, 2008
Evaluation of vessel response to percutaneous coronary interventionPeter J Fitzgerald, Hiromasa Otake
Pageof 213